Celebrity weight loss has always garnered significant media attention, influencing public perceptions of body image and health. Recently, the diabetes medication Ozempic (semaglutide) has gained popularity for its off-label use in weight loss, further fuelling this trend. This article explores the psychological implications of celebrity-endorsed weight loss and the use of Ozempic from a psychologist’s perspective, supported by scientific research.

Ozempic (semaglutide) is a medication originally developed for managing type 2 diabetes. It works by mimicking the hormone GLP-1 (glucagon-like peptide-1), which increases insulin production, decreases glucagon secretion, and slows gastric emptying. These actions help control blood sugar levels (Blonde et al., 2018).

While Ozempic is approved for diabetes management, it has gained attention for its potential in weight loss. Clinical trials have shown that semaglutide can lead to significant weight reduction in obese and overweight individuals (Wilding et al., 2021). This has led to its off-label use for weight loss, often promoted by celebrities.

Celebrities wield substantial influence over public perceptions of beauty and health. Their weight loss journeys, often highlighted in media, can set unrealistic standards for the general public. This phenomenon, known as the “celebrity effect,” can significantly impact body image and self-esteem (Grabe, Ward, & Hyde, 2008).

Social comparison theory posits that individuals determine their own social and personal worth based on how they stack up against others. When people compare themselves to celebrities who have undergone dramatic weight loss, it can lead to negative body image, low self-esteem, and even eating disorders (Festinger, 1954).

Weight loss can improve self-esteem and body image in individuals struggling with obesity. However, the method and context of weight loss matter. Using medications like Ozempic for weight loss, particularly when influenced by celebrity endorsements, can lead to unhealthy body image and unrealistic expectations (Neumark-Sztainer et al., 2006).

Relying on medication for weight loss without addressing underlying lifestyle and psychological issues can lead to dependency and other mental health concerns. Individuals may develop a reliance on the medication for maintaining their weight, neglecting healthier habits such as balanced diet and regular exercise (Bray et al., 2016).

The portrayal of rapid weight loss through medications like Ozempic in media can create unrealistic expectations and pressure to achieve similar results quickly. This can lead to frustration, disappointment, and a cycle of yo-yo dieting, which is detrimental to both physical and mental health (Polivy & Herman, 2002).

Celebrities have a responsibility to promote healthy and realistic standards of beauty and health. Endorsing medications like Ozempic for weight loss without highlighting the potential risks and the importance of medical supervision can be misleading and harmful (Levine & Piran, 2001).

Kim Kardashian is a notable example, often credited with sparking widespread interest in Ozempic for weight loss. Although she has not publicly confirmed using the drug, speculation arose following her significant weight loss leading up to and following the 2022 Met Gala. The dramatic transformation prompted discussions about her potential use of semaglutide-based medications, which are known for their weight loss benefits (Perez, 2023).

Elon Musk, the billionaire entrepreneur, has been more open about his use of Ozempic for weight loss. Musk confirmed via social media that he used the medication to achieve and maintain his weight loss goals. His admission brought significant attention to Ozempic, particularly among those looking for effective weight management solutions (Reynolds, 2022).

Actress and writer Mindy Kaling has also been associated with the use of Ozempic. Known for her candid discussions about body image and weight, Kaling’s noticeable weight loss over the past few years has led to speculation about her use of weight loss medications, including Ozempic. While she has not explicitly confirmed using the drug, the discussions highlight the growing trend of celebrities turning to such medications (Murray, 2023).

In a recent interview, Oprah Winfrey openly discussed her use of Ozempic, after a long period of her hiding her use of the drug, stating that it has significantly contributed to her weight loss efforts. She emphasised that, after many years of struggling with her weight, Ozempic has provided her with an effective tool to manage her health more sustainably (Perez, 2023). Oprah’s admission may shift public perception of weight loss methods, particularly the use of medications like Ozempic. Her endorsement can lead to increased interest and acceptance of pharmacological aids in weight management, potentially reducing the stigma associated with their use (Grabe, Ward, & Hyde, 2008). Oprah’s influence necessitates a discussion on the ethical implications of celebrity endorsements of prescription medications. It is crucial to ensure that the public understands the importance of medical supervision and personalised healthcare when considering such treatments (Levine & Piran, 2001).

Celebrities have a profound influence on public perceptions of health and beauty standards. Their use of Ozempic for weight loss can set unrealistic expectations and pressure for rapid weight loss among their followers. This phenomenon, known as the “celebrity effect,” can significantly impact body image and self-esteem, leading individuals to seek similar results through the same means (Grabe, Ward, & Hyde, 2008).

Social comparison theory suggests that individuals determine their social and personal worth based on how they stack up against others. When celebrities publicly discuss their weight loss journeys using medications like Ozempic, it can lead to negative body image and self-esteem issues among those who compare themselves to these high-profile figures (Festinger, 1954).

The off-label use of Ozempic for weight loss, particularly without medical supervision, can pose significant health risks. These include gastrointestinal issues, potential hypoglycemia, and other side effects associated with inappropriate use of diabetes medications (Astrup & Rössner, 2000). The celebrity endorsements may inadvertently encourage misuse and underestimation of the potential risks.

Scientific studies support the efficacy of semaglutide (Ozempic) in promoting weight loss. Clinical trials have demonstrated that semaglutide can lead to significant weight reduction in individuals with obesity or overweight (Wilding et al., 2021). These studies highlight the medication’s potential but also emphasise the need for proper medical supervision.

Healthcare professionals stress the importance of using medications like Ozempic under medical supervision. Doctors can assess individual health profiles, recommend appropriate dosages, and monitor for side effects. This approach ensures that the benefits of the medication are maximised while minimising potential risks (Bray et al., 2016).

It is crucial for individuals considering weight loss medications like Ozempic to consult healthcare professionals. Medical guidance ensures that the medication is used safely and effectively, considering the individual’s overall health and potential side effects (Astrup & Rössner, 2000).

Psychologists and healthcare professionals advocate for comprehensive lifestyle changes over reliance on medications for weight loss. This includes a balanced diet, regular physical activity, and addressing psychological factors such as stress and emotional eating (Wing & Phelan, 2005).

The use of Ozempic for weight loss, particularly when influenced by celebrity endorsements, raises significant psychological and ethical concerns. While weight loss can positively impact self-esteem and health, it is essential to approach it responsibly, prioritising sustainable lifestyle changes and medical guidance. Celebrities and media have a critical role in promoting healthy, realistic standards and ensuring that their influence contributes positively to public well-being.

• Astrup, A., & Rössner, S. (2000). Lessons from obesity management programmes: greater initial weight loss improves long-term maintenance. Obesity Reviews, 1(1), 17-19.
• Blonde, L., Aschner, P., Bailey, C., Ji, L., Leiter, L. A., Matthaei, S., & Silva-Nunes, J. (2018). Global Partnership for Effective Diabetes Management. Diabetes therapy: Clinical outcomes, health-related quality of life, and treatment satisfaction in patients with type 2 diabetes treated with SGLT2 inhibitors in routine clinical practice. Diabetes Therapy, 9(2), 751-766.
• Bray, G. A., Fruhbeck, G., Ryan, D. H., & Wilding, J. P. (2016). Management of obesity. The Lancet, 387(10031), 1947-1956.
• Festinger, L. (1954). A theory of social comparison processes. Human Relations, 7(2), 117-140.
• Grabe, S., Ward, L. M., & Hyde, J. S. (2008). The role of the media in body image concerns among women: A meta-analysis of experimental and correlational studies. Psychological Bulletin, 134(3), 460-476.
• Levine, M. P., & Piran, N. (2001). Reflections on the role of prevention in the link between sociocultural factors and eating disorders. Eating Disorders, 9(3), 239-250.
• Neumark-Sztainer, D., Wall, M., Haines, J., Story, M., Sherwood, N. E., & van den Berg, P. (2006). Shared risk and protective factors for overweight and disordered eating in adolescents. American Journal of Preventive Medicine, 31(2), 151-157.
• Perez, A. (2023). Oprah Winfrey’s weight loss journey: Her experience with Ozempic. Health & Wellness Today.
• Polivy, J., & Herman, C. P. (2002). Causes of eating disorders. Annual Review of Psychology, 53(1), 187-213.
• Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., … & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002.
• Wing, R. R., & Phelan, S. (2005). Long-term weight loss maintenance. American Journal of Clinical Nutrition, 82(1), 222S-225S.

How to get in touch

If you or your patient/NDIS clients need immediate mental healthcare assistance, feel free to get in contact with us on 1800 NEAR ME – admin@therapynearme.com.au.